Stimulation of mesenchymal stromal cells (MSCs) via TLR3 reveals a novel mechanism of autocrine priming

FASEB Journal

Volumn 28, Issue 9, 2014, Pages 3856-3866

  Dumitru, Claudia A ^a   Hemeda, Hatim ^a,b   Jakob, Mark ^a,c   Lang, Stephan ^a   Brandau, Sven ^a  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

^b RWTH AACHEN UNIVERSITY   (Germany)

^c UNIVERSITY HOSPITAL BONN   (Germany)

Author keywords

Biphasic cytokine response; Functional polarization; Interferon type I; Poly I:C; Proinflammatory cytokines

Indexed keywords

3 (4 METHYLPHENYLSULFONYL) 2 PROPENENITRILE; INTERFERON; INTERFERON REGULATORY FACTOR 3; INTERFERON REGULATORY FACTOR 7; INTERLEUKIN 6; INTERLEUKIN 8; LIGAND; POLYINOSINIC POLYCYTIDYLIC ACID; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 10; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 5; TOLL LIKE RECEPTOR 6; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 8; TOLL LIKE RECEPTOR 9; AUTACOID; GAMMA INTERFERON; LIPOPOLYSACCHARIDE; MESSENGER RNA;

ADULT; AGED; ARTICLE; AUTOCRINE EFFECT; CELL ISOLATION; CELL STIMULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; CYTOKINE RESPONSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IMMUNOMODULATION; INFLAMMATION; MALE; MESENCHYMAL STROMA CELL; NOSE MUCOSA; PLASTICITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING; AGONISTS; CELL CULTURE; CYTOLOGY; DRUG EFFECTS; FLUORESCENT ANTIBODY TECHNIQUE; GENETICS; IMMUNOLOGY; METABOLISM; MIDDLE AGED; PATHOLOGY; REAL TIME POLYMERASE CHAIN REACTION;

ADULT; AGED; AUTOCRINE COMMUNICATION; BLOTTING, WESTERN; CELLS, CULTURED; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; INTERFERON-GAMMA; INTERLEUKIN-6; INTERLEUKIN-8; LIPOPOLYSACCHARIDES; MALE; MESENCHYMAL STROMAL CELLS; MIDDLE AGED; NASAL MUCOSA; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TOLL-LIKE RECEPTOR 3;

EID: 84907212871     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.14-250159     Document Type: Article

References (31)

1. Miao, Z., Jin, J., Chen, L., Zhu, J., Huang, W., Zhao, J., Qian, H., and Zhang, X. (2006) Isolation of mesenchymal stem cells from human placenta: comparison with human bone marrow mesenchymal stem cells. Cell Biol. Int. 30, 681-687
2. Nathan, S., Das De, S., Thambyah, A., Fen, C., Goh, J., and Lee, E. H. (2003) Cell-based therapy in the repair of osteochondral defects: a novel use for adipose tissue. Tissue Eng. 9, 733-744
3. Prockop, D. J., Gregory, C. A., and Spees, J. L. (2003) One strategy for cell and gene therapy: harnessing the power of adult stem cells to repair tissues. Proc. Natl. Acad. Sci. U. S. A. 100(Suppl. 1), 11917-11923
4. Jakob, M., Hemeda, H., Janeschik, S., Bootz, F., Rotter, N., Lang, S., and Brandau, S. (2010) Human nasal mucosa contains tissue-resident immunologically responsive mesenchymal stromal cells. Stem Cells Dev. 19, 635-644
5. Bernardo, M. E., and Fibbe, W. E. (2013) Mesenchymal stromal cells: sensors and switchers of inflammation. Cell Stem Cell 13, 392-402
6. Brandau, S., Jakob, M., Hemeda, H., Bruderek, K., Janeschik, S., Bootz, F., and Lang, S. (2010) Tissue-resident mesenchymal stem cells attract peripheral blood neutrophils and enhance their inflammatory activity in response to microbial challenge. J. Leukoc. Biol. 88, 1005-1015
7. Cassatella, M. A., Mosna, F., Micheletti, A., Lisi, V., Tamassia, N., Cont, C., Calzetti, F., Pelletier, M., Pizzolo, G., and Krampera, M. (2011) Toll-like receptor-3-activated human mesenchymal stromal cells significantly prolong the survival and function of neutrophils. Stem Cells 29, 1001-1011
8. English, K., Ryan, J. M., Tobin, L., Murphy, M. J., Barry, F. P., and Mahon, B. P. (2009) Cell contact, prostaglandin E(2) and transforming growth factor beta 1 play non-redundant roles in human mesenchymal stem cell induction of CD4+CD25(High) forkhead box P3+ regulatory T cells. Clin. Exp. Immunol. 156, 149-160
9. Francois, M., Romieu-Mourez, R., Li, M., and Galipeau, J. (2012) Human MSC suppression correlates with cytokine induction of indoleamine 2,3-dioxygenase and bystander M2 macrophage differentiation. Mol. Ther. 20, 187-195
10. Maccario, R., Podesta, M., Moretta, A., Cometa, A., Comoli, P., Montagna, D., Daudt, L., Ibatici, A., Piaggio, G., Pozzi, S., Frassoni, F., and Locatelli, F. (2005) Interaction of human mesenchymal stem cells with cells involved in alloantigen-specific immune response favors the differentiation of CD4+ T-cell subsets expressing a regulatory/suppressive phenotype. Haematologica 90, 516-525
11. Nemeth, K., Leelahavanichkul, A., Yuen, P. S., Mayer, B., Parmelee, A., Doi, K., Robey, P. G., Leelahavanichkul, K., Koller, B. H., Brown, J. M., Hu, X., Jelinek, I., Star, R. A., and Mezey, E. (2009) Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production. Nat. Med. 15, 42-49
12. Selmani, Z., Naji, A., Zidi, I., Favier, B., Gaiffe, E., Obert, L., Borg, C., Saas, P., Tiberghien, P., Rouas-Freiss, N., Carosella, E. D., and Deschaseaux, F. (2008) Human leukocyte antigen-G5 secretion by human mesenchymal stem cells is required to suppress T lymphocyte and natural killer function and to induce CD4+CD25highFOXP3+ regulatory T cells. Stem Cells 26, 212-222
13. Melief, S. M., Schrama, E., Brugman, M. H., Tiemessen, M. M., Hoogduijn, M. J., Fibbe, W. E., and Roelofs, H. (2013) Multi-potent stromal cells induce human regulatory T cells through a novel pathway involving skewing of monocytes toward anti-inflammatory macrophages. Stem Cells 31, 1980-1991
14. Stagg, J., and Galipeau, J. (2013) Mechanisms of immune modulation by mesenchymal stromal cells and clinical translation. Curr. Mol. Med. 13, 856-867
15. Waterman, R. S., Tomchuck, S. L., Henkle, S. L., and Betancourt, A. M. (2010) A new mesenchymal stem cell (MSC) paradigm: polarization into a pro-inflammatory MSC1 or an Immunosuppressive MSC2 phenotype. PLoS One 5, e10088
16. Hwa Cho, H., Bae, Y. C., and Jung, J. S. (2006) Role of toll-like receptors on human adipose-derived stromal cells. Stem Cells 24, 2744-2752
17. Nagai, Y., Garrett, K. P., Ohta, S., Bahrun, U., Kouro, T., Akira, S., Takatsu, K., and Kincade, P. W. (2006) Toll-like receptors on hematopoietic progenitor cells stimulate innate immune system replenishment. Immunity 24, 801-812
18. Pevsner-Fischer, M., Morad, V., Cohen-Sfady, M., Rousso-Noori, L., Zanin-Zhorov, A., Cohen, S., Cohen, I. R., and Zipori, D. (2007) Toll-like receptors and their ligands control mesenchymal stem cell functions. Blood 109, 1422-1432
19. Zhu, J., and Mohan, C. (2010) Toll-like receptor signaling pathways-therapeutic opportunities. Mediators Inflamm. 2010, 781235
20. Hemeda, H., Jakob, M., Ludwig, A. K., Giebel, B., Lang, S., and Brandau, S. (2010) Interferon-gamma and tumor necrosis factor-alpha differentially affect cytokine expression and migration properties of mesenchymal stem cells. Stem Cells Dev. 19, 693-706
21. Dumitru, C. A., Fechner, M. K., Hoffmann, T. K., Lang, S., and Brandau, S. (2012) A novel p38-MAPK signaling axis modulates neutrophil biology in head and neck cancer. J. Leukoc. Biol. 91, 591-598
22. Opitz, C. A., Litzenburger, U. M., Lutz, C., Lanz, T. V., Tritschler, I., Koppel, A., Tolosa, E., Hoberg, M., Anderl, J., Aicher, W. K., Weller, M., Wick, W., and Platten, M. (2009) Toll-like receptor engagement enhances the immunosuppressive properties of human bone marrow-derived mesenchymal stem cells by inducing indoleamine-2,3-dioxygenase-1 via interferon-beta and protein kinase R. Stem Cells 27, 909-919
23. McCormick, C., and Ganem, D. (2005) The kaposin B protein of KSHV activates the p38/MK2 pathway and stabilizes cytokine mRNAs. Science 307, 739-741
24. Patil, C., Zhu, X., Rossa, C., Jr., Kim, Y. J., and Kirkwood, K. L. (2004) p38 MAPK regulates IL-1beta induced IL-6 expression through mRNA stability in osteoblasts. Immunol. Invest. 33, 213-233
25. Winzen, R., Kracht, M., Ritter, B., Wilhelm, A., Chen, C. Y., Shyu, A. B., Muller, M., Gaestel, M., Resch, K., and Holtmann, H. (1999) The p38 MAP kinase pathway signals for cytokine-induced mRNA stabilization via MAP kinase-activated protein kinase 2 and an AU-rich region-targeted mechanism. EMBO J. 18, 4969-4980
26. Khabar, K. S., and Young, H. A. (2007) Post-transcriptional control of the interferon system. Biochimie (Paris) 89, 761-769
27. Honda, K., and Taniguchi, T. (2006) IRFs: master regulators of signalling by Toll-like receptors and cytosolic pattern-recognition receptors. Nat. Rev. Immunol. 6, 644-658
28. Baker, B. J., Akhtar, L. N., and Benveniste, E. N. (2009) SOCS1 and SOCS3 in the control of CNS immunity. Trends Immunol. 30, 392-400
29. Tomchuck, S. L., Henkle, S. L., Coffelt, S. B., and Betancourt, A. M. (2012) Toll-like receptor 3 and suppressor of cytokine signaling proteins regulate CXCR4 and CXCR7 expression in bone marrow-derived human multipotent stromal cells. PLoS One 7, e39592
30. Krampera, M. (2011) Mesenchymal stromal cell 'licensing': a multistep process. Leukemia 25, 1408-1414
31. Melief, S. M., Geutskens, S. B., Fibbe, W. E., and Roelofs, H. (2013) Multipotent stromal cells skew monocytes towards an anti-inflammatory interleukin-10-producing phenotype by production of interleukin-6. Haematologica 98, 888-895